JC: The PATCH trial. TXA in major trauma
Critical Appraisal of the The PATCH trial of TXA Tranexamic Acid in major trauma patients. TXA saves lives, but functional outcomes vary.
JC: The PATCH trial. TXA in major trauma Read More
Critical Appraisal of the The PATCH trial of TXA Tranexamic Acid in major trauma patients. TXA saves lives, but functional outcomes vary.
JC: The PATCH trial. TXA in major trauma Read More
Tranexamic acid in trauma is a well-established standard of care in most mature trauma systems. The two major trials of TXA, CRASH 2 and 3 suggest a small but important
Differential prescribing of TXA by gender. St Emlyn’s Read More
Our regular podcast round up from February 2021. Iain and Simon highlight the key learning points from this month on the St Emlyn’s blog and podcast. Please remember to subscribe
Podcast – February 2021 Monthly Round Up Read More
Is Tranexamic Acid a useful adjunct in the management of epistaxis
JC: Epistaxis – The NoPAC trial – Does TXA work? Read More
This post is co-published with our friends at REBEL EM. Background: It almost seems that when it comes to the use of the antifibrinolytic agent tranexamic acid (TXA) in trauma,
JC: Should we rubber STAAMP prehospital TXA? Read More
Welcome to our audio round up of everything on the blog during September. It’s been a relatively quiet on the blog post this month, but we chat through not only
Podcast – September 2020 Monthly Round Up Read More
Tranexamic Acid (TXA) is a mainstay of trauma management. CRASH 2 (2) demonstrated its effectiveness in bleeding patients and CRASH 3 (1,5) (in my opinion) showed that we should also
JC: Can we give tranexamic acid (TXA) via the IM route? St Emlyn’s Read More
Our post on the CRASH-3 trial, an RCT examining the use of TXA in head injury, was arguably our most controversial of 2019 (1). Our view was that the evidence
JC: TXA in severe head injury. St Emlyn’s Read More